Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐ or second‐line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial-Reference-Cited by-同舟云学术

Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐ or second‐line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial

Published:2020-12-10 Issue:10 Volume:148 Page:2512-2521
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Innominato Pasquale F.¹²³^ORCID,Karaboué Abdoulaye³⁴,Focan Christian⁵,Chollet Philippe⁶,Giacchetti Sylvie³⁷,Bouchahda Mohamed³⁸⁹¹⁰,Ulusakarya Ayhan³¹⁰,Torsello Angela¹¹,Adam René³¹²,Lévi Francis A.²³¹²,Garufi Carlo¹³

Affiliation:

1. North Wales Cancer Centre, Ysbyty Gwynedd, Betsi Cadwaladr University Health Board Bangor UK

2. Cancer Chronotherapy Team, Cancer Research Centre, Division of Biomedical Sciences Warwick Medical School Coventry UK

3. UPR “Chronotherapy, Cancers and Transplantation”, Faculty of Medicine Paris‐Saclay University Villejuif France

4. Medical Oncology Unit GHI Le Raincy‐Montfermeil Montfermeil France

5. Department of Oncology CHC‐MontLegia, Groupe Santé CHC‐Liège Liège Belgium

6. Clinical and Translational Research Division Jean Perrin Comprehensive Cancer Centre Clermont‐Ferrand France

7. Department of Oncology Saint Louis Hospital, Public Hospitals of Paris (AP‐HP) Paris France

8. Medical Oncology Unit Clinique du Mousseau Evry France

9. Medical Oncology Unit Clinique Saint Jean L'Ermitage Melun France

10. Chronotherapy Unit, Department of Medical Oncology Paul Brousse Hospital, Public Hospitals of Paris (AP‐HP) Villejuif France

11. Division of Medical Oncology San Giovanni‐ Addolorata Hospital Rome Italy

12. Hepatobiliary Centre Paul Brousse Hospital, Public Hospitals of Paris (AP‐HP) Villejuif France

13. Division of Medical Oncology San Camillo Forlanini Hospital Rome Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33422

Reference40 articles.

1. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018

2. Colorectal cancer

3. Multidisciplinary approach of liver metastases from colorectal cancer

4. Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

5. Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shaping the future of precision oncology: Integrating circadian medicine and mathematical models for personalized cancer treatment;Current Opinion in Systems Biology;2024-03

2. A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance;Cell Biochemistry and Function;2024-01

3. Circadian clock and lipid metabolism disorders: a potential therapeutic strategy for cancer;Frontiers in Endocrinology;2023-12-22

4. The role of circadian clock genes in colorectal carcinoma: Novel insights into regulatory mechanism and implications in clinical therapy;Life Sciences;2023-11

5. Vitamin C Improves the Inhibitory Effects of Oxaliplatin on HCT-116 Colorectal Cancer Growth and Progression Through Cellular Oxidant Function-associated Cadherin Molecules;Anticancer Research;2023-09-29